{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:32:52Z","timestamp":1697301172972},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12185-010-0658-x","type":"journal-article","created":{"date-parts":[[2010,8,9]],"date-time":"2010-08-09T04:07:29Z","timestamp":1281326849000},"page":"381-385","source":"Crossref","is-referenced-by-count":13,"title":["An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2\u00a0years after cervical plasmacytoma resection"],"prefix":"10.1007","volume":"92","author":[{"given":"Masao","family":"Hagihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Michikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"658_CR1","first-page":"381","volume":"13","author":"SG Johansson","year":"1967","unstructured":"Johansson SG, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967;13:381\u201394.","journal-title":"Immunology"},{"key":"658_CR2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000237490","volume":"112","author":"JM Jako","year":"1997","unstructured":"Jako JM, Gesztesi T, Kaszas I. IgE lambda monoclonal gammopathy and amyloidosis. Int Arch Allergy Immunol. 1997;112:415\u201321.","journal-title":"Int Arch Allergy Immunol"},{"key":"658_CR3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1200\/JCO.2008.20.1491","volume":"27","author":"JL Wozney","year":"2009","unstructured":"Wozney JL, Ahmed F, Bayerl MG, Ehmann WC, Talamo G. Skin involvement in immunoglobulin E multiple myeloma. J Clin Oncol. 2009;27:637\u20138.","journal-title":"J Clin Oncol"},{"key":"658_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00365519950185472","volume":"59","author":"KJ Kairemo","year":"1999","unstructured":"Kairemo KJ, Lindberg M, Prytz M. IgE myeloma: a case presentation and a review of the literature. Scand J Clin Lab Invest. 1999;59:451\u20136.","journal-title":"Scand J Clin Lab Invest"},{"key":"658_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0609.2007.00825.x","volume":"78","author":"MJ Hayes","year":"2007","unstructured":"Hayes MJ, Carey JL, Krauss JC, Hedstrom DL, Gulbranson RL, Keren DF. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma. Eur J Haematol. 2007;78:353\u20137.","journal-title":"Eur J Haematol"},{"key":"658_CR6","first-page":"87","volume":"35","author":"L Lloyd","year":"2003","unstructured":"Lloyd L, Klingberg SL, Kende M, Howell JF, Clague AE. A case of IgE multiple myeloma. Pathology. 2003;35:87\u20139.","journal-title":"Pathology"},{"key":"658_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10330-003-0206-8","volume":"3","author":"J Hou","year":"2004","unstructured":"Hou J, Jiang H, Hu H, He J. IgE myeloma: the first report of Chinese case and a review of the literature. Chin Ger J Clin Oncol. 2004;3:189\u201391.","journal-title":"Chin Ger J Clin Oncol"},{"key":"658_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/00313020903434660","volume":"42","author":"W Chiu","year":"2010","unstructured":"Chiu W, Pullon H, Woon ST, Oei P, The R, Ameratunga R. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia. Pathology. 2010;42:82\u20134.","journal-title":"Pathology"},{"key":"658_CR9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12185-009-0407-1","volume":"90","author":"Y Takemura","year":"2009","unstructured":"Takemura Y, Ikeda M, Kobayashi K, Nakazawa Y, Mori Y, Mitsuishi T, Ishigame H, Kameko F, Fujita K, Ichinohasama R. Plasma cell leukemia producing monoclonal immunoglobulin E. Int J Hematol. 2009;90:402\u20136.","journal-title":"Int J Hematol"},{"key":"658_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000204851","volume":"85","author":"F Invernizzi","year":"1991","unstructured":"Invernizzi F, Monti G, Caviglia AG, Meroni P, Zanussi C. A new case of IgE myeloma. Acta Haematol. 1991;85:41\u20134.","journal-title":"Acta Haematol"},{"key":"658_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/10428199909058419","volume":"32","author":"M Macro","year":"1999","unstructured":"Macro M, Andre I, Comby E, Cheze S, Chapon F, Ballet JJ, Reman O, Leporrier M, Troussard X. IgE multiple myeloma. Leuk Lymphoma. 1999;32:597\u2013603.","journal-title":"Leuk Lymphoma"},{"key":"658_CR12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE. A clinical staging system for multiple myeloma Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842\u201354.","journal-title":"Cancer"},{"key":"658_CR13","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2009-04-202879","volume":"114","author":"RL Comenzo","year":"2009","unstructured":"Comenzo RL. How I treat amyloidosis. Blood. 2009;114:3147\u201357.","journal-title":"Blood"},{"key":"658_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","volume":"122","author":"HJ Lachmann","year":"2003","unstructured":"Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, Hawkins PN. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol. 2003;122:78\u201384.","journal-title":"Br J Haematol"},{"key":"658_CR15","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2005-07-2922","volume":"107","author":"A Dispenzieri","year":"2006","unstructured":"Dispenzieri A, Lacy MQ, Katzmann JA, Rajkumar SV, Abraham RS, Hayman SR, Kumar SK, Clark R, Kyle RA. Litzow MR and others Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2006;107:3378\u201383.","journal-title":"Blood"},{"key":"658_CR16","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860\u201373.","journal-title":"N Engl J Med"},{"key":"658_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/bbmt.2003.50002","volume":"9","author":"T Hahn","year":"2003","unstructured":"Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson JR, Brozeit G, Carver JR, Kyle RA, McCarthy PL Jr. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. Biol Blood Marrow Transpl. 2003;9:4\u201337.","journal-title":"Biol Blood Marrow Transpl"},{"key":"658_CR18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ajh.2830450315","volume":"45","author":"N Yamagata","year":"1994","unstructured":"Yamagata N, Shimazaki C, Goto H, Hirata T, Ashihara E, Oku N, Inaba T, Fujita N, Nakagawa M. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha. Am J Hematol. 1994;45:262\u20134.","journal-title":"Am J Hematol"},{"key":"658_CR19","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S. Goldschmidt H and others Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med. 2005;352:2487\u201398.","journal-title":"N Engl J Med"},{"key":"658_CR20","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood-2007-10-117457","volume":"111","author":"A Palumbo","year":"2008","unstructured":"Palumbo A, Facon T, Sonneveld P, Blade J, Offidani M, Gay F, Moreau P, Waage A, Spencer A, Ludwig H, et al. Thalidomide for treatment of multiple myeloma: 10\u00a0years later. Blood. 2008;111:3968\u201377.","journal-title":"Blood"},{"key":"658_CR21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.11325","volume":"92","author":"E Kastritis","year":"2007","unstructured":"Kastritis E, Anagnostopoulos A, Roussou M, Toumanidis S, Pamboukas C, Migkou M, Tassidou A, Xilouri I, Delibasi S, Psimenou E, et al. Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone. Haematologica. 2007;92:1351\u20138.","journal-title":"Haematologica"},{"key":"658_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3324\/haematol.11627","volume":"93","author":"AD Wechalekar","year":"2008","unstructured":"Wechalekar AD, Lachmann HJ, Offer M, Hawkins PN, Gillmore JD. Efficacy of bortezomib in systemic AL amyloidosis with relapsed\/refractory clonal disease. Haematologica. 2008;93:295\u20138.","journal-title":"Haematologica"},{"key":"658_CR23","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2004-08-3231","volume":"105","author":"G Palladini","year":"2005","unstructured":"Palladini G, Perfetti V, Perlini S, Obici L, Lavatelli F, Caccialanza R, Invernizzi R, Comotti B, Merlini G. The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL). Blood. 2005;105:2949\u201351.","journal-title":"Blood"},{"key":"658_CR24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood-2006-07-035352","volume":"109","author":"AD Wechalekar","year":"2007","unstructured":"Wechalekar AD, Goodman HJ, Lachmann HJ, Offer M, Hawkins PN, Gillmore JD. Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis. Blood. 2007;109:457\u201364.","journal-title":"Blood"},{"key":"658_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00277-008-0600-y","volume":"88","author":"G Palladini","year":"2009","unstructured":"Palladini G, Russo P, Lavatelli F, Nuvolone M, Albertini R, Bosoni T, Perfetti V, Obici L, Perlini S, Moratti R, et al. Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide. Ann Hematol. 2009;88:347\u201350.","journal-title":"Ann Hematol"},{"key":"658_CR26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1253\/circj.71.1823","volume":"71","author":"JS Choi","year":"2007","unstructured":"Choi JS, Hwang EN, Kim YH, Jung Y, Kim HJ, Nam SH, Park JI. Improvement after thalidomide and dexamethasone treatment for advanced cardiac amyloidosis: a case report. Circ J. 2007;71:1823\u20135.","journal-title":"Circ J"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0658-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0658-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0658-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T04:15:12Z","timestamp":1591762512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0658-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0658-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}